D. Agnusdei

4.4k total citations
83 papers, 2.9k citations indexed

About

D. Agnusdei is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Genetics. According to data from OpenAlex, D. Agnusdei has authored 83 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Orthopedics and Sports Medicine, 24 papers in Molecular Biology and 24 papers in Genetics. Recurrent topics in D. Agnusdei's work include Bone health and osteoporosis research (46 papers), Estrogen and related hormone effects (24 papers) and Bone Metabolism and Diseases (21 papers). D. Agnusdei is often cited by papers focused on Bone health and osteoporosis research (46 papers), Estrogen and related hormone effects (24 papers) and Bone Metabolism and Diseases (21 papers). D. Agnusdei collaborates with scholars based in Italy, United States and Belgium. D. Agnusdei's co-authors include C. Gennari, Roberto Civitelli, Paolo Nardi, L. Bufalino, Stefano Gonnelli, Cyrus Cooper, J. A. Kanis, R Nami, F Zacchei and U. A. Liberman and has published in prestigious journals such as The Lancet, Circulation Research and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

D. Agnusdei

79 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Agnusdei Italy 30 1.5k 949 799 619 613 83 2.9k
N Frisina Italy 36 410 0.3× 767 0.8× 733 0.9× 259 0.4× 1.1k 1.8× 112 4.0k
Richard Keen United Kingdom 31 1.1k 0.7× 673 0.7× 419 0.5× 370 0.6× 564 0.9× 92 2.8k
Antonino Lasco Italy 24 587 0.4× 502 0.5× 540 0.7× 163 0.3× 444 0.7× 71 2.4k
Noriko Yoshimura Japan 28 511 0.3× 482 0.5× 224 0.3× 727 1.2× 763 1.2× 83 2.8k
Yosef Weisman Israel 33 520 0.3× 494 0.5× 310 0.4× 210 0.3× 1.8k 2.9× 96 3.3k
Elizabeth Barrett-Connor United States 8 584 0.4× 299 0.3× 293 0.4× 243 0.4× 319 0.5× 8 2.3k
G. Kerr Whitfield United States 26 176 0.1× 974 1.0× 652 0.8× 423 0.7× 1.9k 3.1× 39 3.5k
Stephen P. Coburn United States 27 621 0.4× 924 1.0× 237 0.3× 308 0.5× 390 0.6× 85 3.1k
Rosemary Bland United Kingdom 29 314 0.2× 614 0.6× 233 0.3× 273 0.4× 1.5k 2.4× 48 3.1k
Liesbet Lieben Belgium 18 485 0.3× 660 0.7× 203 0.3× 195 0.3× 1.8k 2.9× 44 2.9k

Countries citing papers authored by D. Agnusdei

Since Specialization
Citations

This map shows the geographic impact of D. Agnusdei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Agnusdei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Agnusdei more than expected).

Fields of papers citing papers by D. Agnusdei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Agnusdei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Agnusdei. The network helps show where D. Agnusdei may publish in the future.

Co-authorship network of co-authors of D. Agnusdei

This figure shows the co-authorship network connecting the top 25 collaborators of D. Agnusdei. A scholar is included among the top collaborators of D. Agnusdei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Agnusdei. D. Agnusdei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harvey, Nicholas C., Kate A. Ward, D. Agnusdei, et al.. (2024). Optimisation of vitamin D status in global populations. Osteoporosis International. 35(8). 1313–1322. 12 indexed citations
2.
Gennari, C. & D. Agnusdei. (2015). Calciotropic Hormones and Pain. Contributions to nephrology. 91. 86–94.
3.
Díez‐Pérez, Adolfo, Jonathan D. Adachi, D. Agnusdei, et al.. (2012). Treatment failure in osteoporosis. Osteoporosis International. 23(12). 2769–2774. 156 indexed citations
4.
Goldstein, Steven R., Claire S. Duvernoy, Joaquím Calaf, et al.. (2009). Raloxifene use in clinical practice. Menopause The Journal of The North American Menopause Society. 16(2). 413–421. 30 indexed citations
5.
Adámi, S., Giancarlo Isaia, G. Luisetto, et al.. (2008). Osteoporosis treatment and fracture incidence: the ICARO longitudinal study. Osteoporosis International. 19(8). 1219–1223. 21 indexed citations
6.
Reginster, Jean‐Yves, Somnath Sarkar, Brigitte Zegels, et al.. (2003). Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk. Bone. 34(2). 344–351. 80 indexed citations
7.
Agnusdei, D., et al.. (2000). Selective Estrogen Receptor Modulators (SERMs): Effects on Multiple Organ Systems. Current Medicinal Chemistry. 7(5). 577–584. 7 indexed citations
8.
Reginster, Jean‐Yves, et al.. (1999). Association of tibolone and fluoride displays a pronounced effect on bone mineral density in postmenopausal osteoporotic women. Gynecological Endocrinology. 13(5). 361–368. 8 indexed citations
9.
Agnusdei, D., et al.. (1999). Tolerability profile of SERMs. Journal of Endocrinological Investigation. 22(8). 641–645. 4 indexed citations
10.
Gennari, C., S. Adámi, D. Agnusdei, et al.. (1997). Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass. Calcified Tissue International. 61(S1). S19–S22. 35 indexed citations
11.
Aj, Silman, J. Varlow, D. Agnusdei, et al.. (1995). Effect of physical activity on the risk of vertebral deformity. Journal of Bone and Mineral Research. 10. 1 indexed citations
12.
Aj, Silman, J. Varlow, D. Agnusdei, et al.. (1995). Hormonal and gynaecological factors and risk of vertebral deformity. Journal of Bone and Mineral Research. 10. 1 indexed citations
13.
Gennari, C., et al.. (1994). Management of Osteoporosis and Paget??s Disease. Drug Safety. 11(3). 179–195. 8 indexed citations
14.
Gennari, C., D. Agnusdei, M Montagnani, Stefano Gonnelli, & Roberto Civitelli. (1992). An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss. Calcified Tissue International. 50(4). 381–383. 59 indexed citations
15.
Overgaard, Kirsten, D. Agnusdei, M.A. Hansen, et al.. (1991). Dose-Response Bioactivity and Bioavailability of Salmon Calcitonin in Premenopausal and Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism. 72(2). 344–349. 54 indexed citations
16.
Gennari, C., Stefano Gonnelli, D. Agnusdei, & Roberto Civitelli. (1990). Biological activity of different calcitonins in men. Experimental Gerontology. 25(3-4). 339–347. 8 indexed citations
17.
Gennari, C., et al.. (1990). Improved cardiac performance with human calcitonin gene related peptide in patients with congestive heart failure. Cardiovascular Research. 24(3). 239–241. 64 indexed citations
18.
Gennari, C., D. Agnusdei, Stefano Gonnelli, & Paolo Nardi. (1989). Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study. Maturitas. 11(3). 187–197. 18 indexed citations
19.
Gennari, C., et al.. (1989). Acute Cardiovascular and Renal Effects of Human Calcitonin Gene-Related Peptide. American Journal of Hypertension. 2(2 Pt 2). 45S–49S. 9 indexed citations
20.
Civitelli, Roberto, D. Agnusdei, Paolo Nardi, et al.. (1988). Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1α-hydroxylase reserve in postmenopausal osteoporosis. Calcified Tissue International. 42(2). 77–86. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N Frisina Breakdown of academic impact, for papers by Richard Keen Breakdown of academic impact, for papers by Antonino Lasco Breakdown of academic impact, for papers by Noriko Yoshimura Breakdown of academic impact, for papers by Yosef Weisman Breakdown of academic impact, for papers by Elizabeth Barrett-Connor Breakdown of academic impact, for papers by G. Kerr Whitfield Breakdown of academic impact, for papers by Stephen P. Coburn Breakdown of academic impact, for papers by Rosemary Bland Breakdown of academic impact, for papers by Liesbet Lieben
Rankless by CCL
2026